CD30-positive malignant lymphomas: time for a change of management?

被引:5
|
作者
Engert, Andreas [1 ,2 ]
机构
[1] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[2] Univ Hosp Cologne, GHSG, Cologne, Germany
关键词
BRENTUXIMAB VEDOTIN SGN-35; STERNBERG-REED CELLS; HODGKINS LYMPHOMA; DISEASE; POTENT;
D O I
10.3324/haematol.2013.091561
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1165 / 1168
页数:5
相关论文
共 50 条
  • [11] Genetic alterations in CD30-positive lymphoproliferations
    Maurus, K.
    Roth, S.
    Appenzeller, S.
    Goebeler, M.
    Rosenwald, A.
    Geissinger, E.
    Wobser, M.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S14 - S15
  • [12] Pityriasis lichenoides with CD30-positive lymphocytes
    Cernik, Christina
    Kadin, Marshall
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB139 - AB139
  • [13] Brentuximab vedotin for CD30-positive tumours
    Masuda, Shigeo
    Miyagawa, Shigeru
    Nakamura, Terumi
    Khurram, Maaz Asher
    Sawa, Yoshiki
    LANCET ONCOLOGY, 2016, 17 (09): : E371 - E371
  • [14] CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis
    Gorczyca, W
    Tsang, P
    Liu, Z
    Wu, CD
    Dong, HY
    Goldstein, M
    Cohen, P
    Gangi, M
    Weisberger, J
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 22 (02) : 319 - 324
  • [15] CD30-positive T-cell lymphomas co-expressing CD15: An immunohistochemical analysis
    Gorczyca, W
    Liu, Z
    Gangi, M
    Weisberger, J
    MODERN PATHOLOGY, 2003, 16 (01) : 233A - 234A
  • [16] IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas
    McQuaid, Daniel C.
    Katz, Samuel G.
    Xu, Mina L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (02) : 173 - 176
  • [17] CD30-positive T-cell lymphomas co-expressing CD15: An immunohistochemical analysis
    Gorczyca, W
    Liu, Z
    Gangi, M
    Weisberger, J
    LABORATORY INVESTIGATION, 2003, 83 (01) : 233A - 234A
  • [18] Rezidivierende CD30-positive kutane lymphoproliferative Erkrankung
    Kamenica, Erdisa
    Wesselmann, Ulrich
    Schmalz, Oliver
    Hofmann, Silke C.
    AKTUELLE DERMATOLOGIE, 2024, 50 (04) : 175 - 179
  • [19] Apoptosis in CD30-positive lymphoproliferative disorders of the skin
    Greisser, J
    Doebbeling, U
    Roos, M
    Mueller, B
    Schmid, M
    Burg, G
    Kadin, ME
    Kempf, W
    EXPERIMENTAL DERMATOLOGY, 2005, 14 (05) : 380 - 385
  • [20] Primary cutaneous CD30-positive lymphoproliferative disorders
    Willenize, R
    Meijer, CJLM
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (06) : 1319 - +